| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43K | — |
| Gross Profit | $43K | — |
| R&D Expense | $6.0M | +6.3% |
| SG&A Expense | $5.0M | -12.9% |
| Operating Income | -$11.0M | +3.7% |
| Net Income | -$8.8M | +13.9% |
| EPS (Basic) | -$0.40 | +59.6% |
| EPS (Diluted) | -$0.40 | +59.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | +509.9% |
| Accounts Receivable | $43K | — |
| Current Assets | $7.8M | +434.0% |
| Total Assets | $8.1M | +453.8% |
| Current Liabilities | $1.9M | +62.5% |
| Total Liabilities | $3.6M | -18.5% |
| Stockholders' Equity | $4.5M | +249.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | +11.0% |
| Capital Expenditures | $12K | — |
| Investing Cash Flow | -$12K | -100.6% |
| Financing Cash Flow | $15.1M | +201.9% |
| Free Cash Flow | -$9.1M | — |